全文获取类型
收费全文 | 397199篇 |
免费 | 36819篇 |
国内免费 | 27544篇 |
专业分类
耳鼻咽喉 | 3022篇 |
儿科学 | 5201篇 |
妇产科学 | 4457篇 |
基础医学 | 43548篇 |
口腔科学 | 6566篇 |
临床医学 | 55893篇 |
内科学 | 54001篇 |
皮肤病学 | 4340篇 |
神经病学 | 19248篇 |
特种医学 | 14813篇 |
外国民族医学 | 233篇 |
外科学 | 35680篇 |
综合类 | 73747篇 |
现状与发展 | 89篇 |
一般理论 | 33篇 |
预防医学 | 29091篇 |
眼科学 | 11195篇 |
药学 | 43065篇 |
451篇 | |
中国医学 | 25631篇 |
肿瘤学 | 31258篇 |
出版年
2024年 | 1344篇 |
2023年 | 5733篇 |
2022年 | 15077篇 |
2021年 | 19210篇 |
2020年 | 15083篇 |
2019年 | 12296篇 |
2018年 | 12844篇 |
2017年 | 12338篇 |
2016年 | 11423篇 |
2015年 | 17724篇 |
2014年 | 22080篇 |
2013年 | 20156篇 |
2012年 | 29756篇 |
2011年 | 33610篇 |
2010年 | 22641篇 |
2009年 | 18381篇 |
2008年 | 22583篇 |
2007年 | 22398篇 |
2006年 | 21354篇 |
2005年 | 20410篇 |
2004年 | 13660篇 |
2003年 | 13212篇 |
2002年 | 10865篇 |
2001年 | 9289篇 |
2000年 | 8986篇 |
1999年 | 9024篇 |
1998年 | 5672篇 |
1997年 | 5512篇 |
1996年 | 4233篇 |
1995年 | 3971篇 |
1994年 | 3333篇 |
1993年 | 2187篇 |
1992年 | 2629篇 |
1991年 | 2315篇 |
1990年 | 1952篇 |
1989年 | 1693篇 |
1988年 | 1396篇 |
1987年 | 1301篇 |
1986年 | 1055篇 |
1985年 | 741篇 |
1984年 | 414篇 |
1983年 | 297篇 |
1982年 | 157篇 |
1981年 | 186篇 |
1980年 | 137篇 |
1979年 | 199篇 |
1978年 | 95篇 |
1977年 | 60篇 |
1974年 | 62篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
5.
6.
7.
8.
目的探讨指压天枢穴加腹部按摩联合番泻叶在静脉肾盂造影患者中的应用效果。方法选取我院2018年12月至2019年8月期间行静脉肾盂造影的120例患者,随机分为两组各60例。对照组给予番泻叶,观察组给予天枢穴指压加腹部按摩联合番泻叶,比较两组的肠道清洁力度和不良反应情况。结果治疗后,观察组的肠道清洁力度明显高于对照组(P <0.05);观察组的不良反应发生率为6.67%,明显低于对照组的23.33%(P <0.05)。结论静脉肾盂造影患者采用指压天枢穴加腹部按摩联合番泻叶的效果较好,可提高肠道清洁力度,降低不良反应发生率。 相似文献
9.
10.
Xiujuan Tian Zhiying Chen Shaomin Shi Xianwen Wang Wanli Wang Ning Li Jing Wang 《Medicine》2015,94(37)
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), is one of the most leading causes of cancers worldwide. Due to a low 5-year survival rate, highly effective methods for the early detection of OSCC are totally needed. MicroRNAs (miRNAs), as promising biomarkers, can bring insights into tumorigenesis of oral cancers. However, studies on the accuracy of miRNAs detection in OSCC have inconsistent conclusions, leading us to conduct this meta-analysis. The aim of this study was to systematically review the articles investigating the diagnostic value of miRNAs in OSCC.The PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), Web of Science were searched (updated to June 11th, 2015) to identify all articles evaluating the diagnostic yield of miRNAs for OSCC. The pooled sensitivity, specificity, and other diagnostic parameters were used to assess the performance of miRNAs assays on OSCC detection. Statistical analysis was conducted by employing the R software.The present meta-analysis comprised 23 studies from 10 articles, including 598 OSCC patients and 320 healthy individuals, available for analysis. The summary receiver operator characteristic (SROC) curve was plotted. Meanwhile, the pooled diagnostic parameters and the area under curve (AUC) were calculated based on all included studies. The pooled diagnostic parameters calculated from all 23 studies were as follows: pooled sensitivity of 0.759 (95% CI: 0.701–0.809), pooled specificity of 0.773 (95% CI: 0.713–0.823) and AUC of 0.832, which indicates a relatively high diagnostic accuracy of miRNAs in differentiating OSCC patients from healthy controls. Meanwhile, In addition, subgroup analyses were conducted to access the heterogeneity between studies, which is based on specimen (serum/plasma/blood/saliva/ tissue) and ethnicity (Asian/Caucasian).In summary, our meta-analysis suggests that miRNAs might be used in noninvasive screening tests for OSCC, which needs further large-scale studies to be validated. 相似文献